Howton David Tyronne's most recent trade in Solid Biosciences Inc was a trade of 14,687 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 14,687 | 29,376 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 14,687 | 112,546 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 13 Feb 2026 | 7,469 | 105,077 (0%) | 0% | 5.8 | 43,494 | Common Stock |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.44 per share. | 04 Feb 2026 | 18,894 | 97,859 (0%) | 0% | 6.4 | 121,713 | Common Stock |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 210,200 | 210,200 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 105,100 | 105,100 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 79,341 | 112,249 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 79,341 | 0 | - | - | Performance Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 42,275 | 126,825 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 42,275 | 154,254 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.44 per share. | 29 Jan 2026 | 37,771 | 116,753 (0%) | 0% | 6.4 | 243,128 | Common Stock |
| Solid Biosciences Inc | Tyronne David Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 13,051 | 13,052 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Howton Tyronne | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 13,051 | 37,840 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Howton David Tyronne | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.11 per share. | 02 Dec 2025 | 4,932 | 32,908 (0%) | 0% | 5.1 | 25,203 | Common Stock |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,687 | 30,350 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,687 | 44,063 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 5,561 | 24,789 (0%) | 0% | 4.0 | 22,022 | Common Stock |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 169,100 | 169,100 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Tyronne David Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 13,051 | 26,103 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Howton David Tyronne | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 13,051 | 20,735 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Tyronne Howton David | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 5,072 | 15,663 (0%) | 0% | 5.6 | 28,396 | Common Stock |
| Solid Biosciences Inc | David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 117,500 | 117,500 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Howton Tyronne David | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 58,750 | 58,750 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Howton David Tyronne | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 13,051 | 39,154 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Howton Tyronne David | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 13,051 | 13,051 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Howton David Tyronne | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 02 Dec 2023 | 5,367 | 7,684 (0%) | 0% | 2.8 | 14,920 | Common Stock |